|
Delayed
NSE India S.E.
05:34:40 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 2,384.50 INR | +2.87% |
|
+2.33% | +17.10% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
Stock exchange
NSE India S.E.
GLENMARK 2,384.50 ₹
+2.87%
1.52B
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLENMARK | 2,384.50INR | +2.87% | 1.52B ₹ | ||
Bombay S.E.
| GLENMARK | 2,386.60INR | +3.50% | 168M ₹ |
Quotes 5-day view: Glenmark Pharmaceuticals Limited
Delayed Quote NSE India S.E.
| 2026-08-18 | 2026-08-19 | 2026-08-20 | 2026-08-21 | 2026-08-24 | |
|---|---|---|---|---|---|
| Last | ₹2,305.00 | ₹2,246.50 | ₹2,332.90 | ₹2,317.90 | ₹2,384.50 |
| Volume | 379,551 | 833,583 | 552,157 | 237,421 | 639,004 |
| Change | -1.03% | -2.54% | +3.85% | -0.64% | +2.87% |
| Opening | ₹2,317.40 | ₹2,301.00 | ₹2,264.00 | ₹2,334.60 | ₹2,315.10 |
| High | ₹2,332.90 | ₹2,313.90 | ₹2,342.00 | ₹2,348.60 | ₹2,385.50 |
| Low | ₹2,305.00 | ₹2,222.50 | ₹2,252.10 | ₹2,303.00 | ₹2,295.30 |
Performance
| 1 day | +2.82% | ||
| 1 week | +2.33% | ||
| Current month | +6.68% | ||
| 1 month | +8.72% | ||
| 3 months | +1.98% | ||
| 6 months | +15.77% | ||
| Current year | +17.10% | ||
| 1 year | +21.83% | ||
| 3 years | +218.12% | ||
| 5 years | +356.86% | ||
| 10 years | +178.33% |
Volumes
marketsDaily volume
639,004
Estimated daily volume
904,596
Avg. Volume 20 sessions
499,448
Daily volume ratio
1.81
Avg. Volume 20 sessions INR
1,190,933,756
Avg. Volume 20 sessions USD
12,440,494.02
Record volume 1
89,266,590
Record volume 2
65,123,680
Record volume 3
39,631,540
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (INR)
654,113,255,218
Market Cap (USD)
6,836,525,130
Net sales (INR)
169,825,110,000
Net sales (USD)
1,774,942,830
Number of employees
16,946
Sales / Employee (INR)
10,021,545
Sales / Employee (USD)
104,741
Free-Float
51.04 %
Free-Float capitalization (INR)
333,898,082,143
Free-Float capitalization (USD)
3,489,766,659
Average Daily Capital Traded
0.18%
Indicators
Moving average 5 days
2,306.26
Moving average 20 days
2,259.54
Moving average 50 days
2,232.3
Moving average 100 days
2,250.28
Price spread / (MMA5)
-3.28%
Price spread / (MMA20)
-5.24%
Price spread / (MMA50)
-6.38%
Price spread / (MMA100)
-5.63%
STIM
RSI 9 days
60.83
RSI 14 days
58.93
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.87% | +2.33% | +21.83% | +218.12% | 6.84B | |
| +0.37% | +1.49% | +15.29% | +70.79% | 47.71B | |
| +0.12% | +1.62% | +52.24% | +123.18% | 40.3B | |
| +0.28% | +0.31% | -10.32% | +17.66% | 12.09B | |
| -1.71% | -2.65% | +7.66% | +71.88% | 11.68B | |
| +0.19% | +0.58% | +30.98% | +158.71% | 9.19B | |
| +3.18% | +2.31% | +25.59% | +45.75% | 7.57B | |
| -0.16% | +1.47% | +46.74% | -11.64% | 7.24B | |
| -5.36% | -6.36% | -38.04% | +22.49% | 5.42B | |
| -1.76% | -3.67% | +36.61% | +108.52% | 4.75B | |
| Average | -0.17% | -1.09% | +18.86% | +82.55% | 15.28B | |
| Weighted average by Cap. | +0.10% | -0.58% | +24.44% | +86.68% |
Historical Quotes: Glenmark Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
a.YLF8QU9LgNMsYb1E1RDXNImpvZvYL_A8Fg75tMpBkfc.JetOJScY9JZ5KPs8tFulXPPCi9GvdopKIEeMxLIO5KgnxkoALgLKl24q_A
| Date | Price | Volume | Total |
|---|---|---|---|
| 05:34:40 | 2,384.50 | 1 | 639,004 |
| 05:34:38 | 2,383.70 | 2 | 639,003 |
| 05:34:36 | 2,383.70 | 2 | 639,001 |
| 05:34:35 | 2,383.70 | 19 | 638,999 |
| 05:34:33 | 2,384.50 | 22 | 638,980 |
| 05:34:31 | 2,384.60 | 2 | 638,958 |
| 05:34:30 | 2,384.60 | 21 | 638,956 |
| 05:34:28 | 2,384.60 | 26 | 638,935 |
| 05:34:27 | 2,383.70 | 378 | 638,909 |
| 05:34:26 | 2,384.80 | 1 | 638,531 |
Course Extremes
| 1 week | 2,222.5 |  | 2,385.5 |
| 1 month | 2,162 | | 2,385.5 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
Monthly variations
Annual variations
| 2026 | +13.89% | ||
| 2025 | +26.48% | ||
| 2024 | +88.43% | ||
| 2023 | +101.33% | ||
| 2022 | -19.75% | ||
| 2021 | +7.10% | ||
| 2020 | +42.03% | ||
| 2019 | -49.87% | ||
| 2018 | +16.53% | ||
| 2017 | -33.06% | ||
| 2016 | -3.63% | ||
| 2015 | +19.70% | ||
| 2014 | +44.27% | ||
| 2013 | +1.00% | ||
| 2012 | +80.05% | ||
| 2011 | -18.93% | ||
| 2010 | +31.27% | ||
| 2009 | -6.84% | ||
| 2008 | -50.32% | ||
| 2007 | +97.78% | ||
| 2006 | +92.22% | ||
| 2005 | +29.33% | ||
| 2004 | +238.85% | ||
| 2003 | +198.25% | ||
| 2002 | +26.86% | ||
| 2001 | -7.37% | ||
| 2000 | -62.36% |
- Stock Market
- Stocks
- GLENMARK Stock
- Quotes Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
